Swiss lender UBS is in talks to sell its hedge fund unit, O'Connor, to U.S. brokerage Cantor Fitzgerald, Bloomberg News reported on Thursday, citing people familiar with the matter.

UBS Group AG is in talks to sell its hedge fund unit O’Connor to Cantor Fitzgerald LP, a move that would end a more than three-decade run of ownership by the Swiss bank, according to people familiar ...

Fintel reports that on May 7, 2025, Cantor Fitzgerald downgraded their outlook for Marvell Technology (NasdaqGS:MRVL) from ...

Cantor Fitzgerald is maintaining a bearish stance on equities, cautioning that the recent market rebound which has been driven largely by investor positioning—is likely behind us. The firm ...

UBS Group (NYSE:UBS) is in discussions to sell its O'Connor hedge fund unit to Cantor Fitzgerald. A potential deal may ...

On Tuesday, Cantor Fitzgerald analyst Sarah James reaffirmed an Overweight rating on CVS Health (NYSE:CVS) with a steady price target of $71.00. The rating aligns with the company’s strong ...

Fintel reports that on May 5, 2025, Cantor Fitzgerald downgraded their outlook for Onto Innovation (BMV:ONTO) from Overweight to Neutral. There are 501 funds or institutions reporting positions in ...

Cantor Fitzgerald is maintaining a bearish stance on equities, cautioning that the recent market rebound which has been ...

Cantor Fitzgerald & Co. acted as the sole book-running manager for the offering. About Cantor Equity Partners II, Inc. Cantor Equity Partners II, Inc. is a blank check company sponsored by Cantor ...

On Monday, Cantor Fitzgerald analysts revised their stance on Onto Innovation Inc. (NYSE:ONTO), downgrading the stock from Overweight to Neutral and significantly reducing the price target to $135 ...